Rebody Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 9/10
Best for: semaglutide from $420.99/month
What Rebody Health does best is price: it charges less than most sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked August 2026
Prices are published up front: compounded semaglutide from about $199.99/mo and compounded tirzepatide from about $249.99/mo as weekly injections, with daily oral melt tablets and brand-name Wegovy and Zepbound also sold, and dose-based pricing shown before each refill. Compound Technologies Inc. operates the brand in 47 states, excluding Massachusetts, Rhode Island and Vermont. Rebody is not a pharmacy, and the licensed compounding pharmacies that prepare its prescriptions are not named on the site.
Is Rebody Health legit?
Yes. Rebody Health is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 9.0/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Rebody Health promo or coupon code?
We know of no promo or coupon code for Rebody Health. Its listed price is $199.99 a month. Coupon sites advertising "Rebody Health discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Rebody Health compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Rebody Health
Editorial score · methodology
Editorial score · methodology
Embody
Best for: knowing which pharmacy fills the vial: it names RedRock Pharmacy
Editorial score · methodology
Rebody Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199.99/mo
- Pricing model
- Rises with the dose: higher doses cost more
- What's included
- Medication · Consult
- Availability
- 47 states
- FDA status
- No FDA warning letters found
How Rebody Health scores
Six columns, each one computed from something Rebody Health has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
10.0/10$420.99/month is 58% below the $997 median for brand-name semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
8.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
9.5/10Serves 47 of 50 states.
Support10%
5.5/10The price covers the medication and clinician visits.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Rebody Health
Last checked August 2026- Checked the listed price across 4 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Rebody Health
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Rebody Health involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Rebody Health shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Rebody Health which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication and clinician visits.
- Lowest ongoing monthly price: semaglutide $420.99, tirzepatide $573.99. That leaves out membership fees, first-month rates and insurance copays.
- Rebody Health serves 47 of 50 states, so check that yours is one of them.
GLP-1 medications Rebody Health offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Weekly compounded injection from $199.99/mo, dose-scaled higher as the prescription increases; daily oral 'melt' semaglutide from $143.99/mo. $50 off first month.
Weekly compounded injection from $249.99/mo, dose-scaled higher as the prescription increases; daily oral 'melt' tirzepatide from $249.99/mo.
Brand Wegovy weekly pen from $420.99/mo; Wegovy oral tablets from $343.99/mo.
Brand Zepbound KwikPen from $573.99/mo.
Check the price yourself before you pay
Every figure here was read off Rebody Health's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $420.99 a month, 58% below the $997 median for brand-name semaglutide across the sellers we compare
- Tirzepatide costs $573.99 a month, 54% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and clinician visits
- Serves 47 states
- We found no FDA warning letters issued to Rebody Health
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Rebody Health charges
Rebody Health lists $199.99/month.
- Compounded semaglutide: $199.99/month
- Compounded tirzepatide: $249.99/month
- Brand-name semaglutide: $420.99/month
- Brand-name tirzepatide: $573.99/month
For brand-name semaglutide, the median across the sellers we compare is $997/month, so Rebody Health's $420.99 is genuinely below the middle, not just advertised that way.
HumeCare+ dispenses semaglutide and tirzepatide from $199/month, which makes it the fair comparison to run before you commit here.
What Rebody Health dispenses
Rebody Health prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. You can take the approved brand pen or the cheaper compounded preparation. What separates them is review: the approved product went through it, the compounded one did not, and that is the whole of the trade.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Rebody Health at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
Rebody Health tells you its price before you start the medical questionnaire and that it treats patients in all 50 states. We found no FDA warning letters issued to Rebody Health. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Rebody Health will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You need insurance to cover the cost. Check whether Rebody Health bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- injections are the thing keeping you from starting
- you need access wherever you live
Our read
Rebody Health competes on price without an obvious sacrifice elsewhere: $420.99/month for brand-name semaglutide, no FDA warning letters, and wide state coverage.
The Bottom Line
What Rebody Health does best is price: it charges less than most sellers we compare.
Before you pay Rebody Health
Starting at $199.99 a month. Check today's price, then start the intake.
Where Rebody Health is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider Sesame Care (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare Rebody Health head to head
The sellers closest to Rebody Health on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Rebody Health review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Rebody Health's current pricing
Plans start at $199.99 a month. Whether you qualify is a clinician's decision, made after your intake.